Document is current
Any future updates will be listed below
-
Authors
Benedict, Ágnes https://orcid.org/0000-0002-4747-4575
Hankosky, Emily R. https://orcid.org/0000-0001-9934-584X
Marczell, Kinga https://orcid.org/0000-0002-1714-7581
Chen, Jieling https://orcid.org/0000-0001-5928-4034
Klein, David J.
Caro, J. Jaime https://orcid.org/0000-0001-5470-3754
Bae, Jay P. https://orcid.org/0000-0002-2322-1450
Benneyworth, Brian D. https://orcid.org/0000-0002-4692-5303
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Accepted: 18 April 2022
First Online: 7 June 2022
Declarations
:
: This study was funded by Eli Lilly and Company.
: ÁB, KM, JJC and DJK are employees of Evidera PPD, a consultancy that provides services to the pharmaceutical industry. Payments are made to Evidera PPD. ERH, JC, BDB and JPB are full-time employees of Eli Lilly and Company. ERH, JC, JPB and BDB hold stocks in Eli Lilly and Company.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.
: Not applicable.
: Á Benedict, ER Hankosky, K Marczell, J Chen made substantial contributions to concept, design of the review, analysis and interpretation as well as the drafting of the manuscript. D Klein, JJ Caro, JP Bae and BD Benneyworth contributed to the design, analysis and interpretation. The manuscript was drafted by Á Benedict, ER Hankosky, K Marczell, J Chen and JJ Caro. DJ Klein and JP Bae provided critical revision of the manuscript for important intellectual content. All authors participated sufficiently in the work to agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
